Curon Biopharmaceutical's Series A Round

Curon Biopharmaceutical raised a round of funding on July 27, 2018.

Curon Biopharmaceutical (同润生物) is a drug developer focused on cancer immuno-therapies.…

Articles about Curon Biopharmaceutical's Series A Round: